T K Mutabingwa

Summary

Publications

  1. ncbi request reprint Artemisinin-based combination therapies (ACTs): best hope for malaria treatment but inaccessible to the needy!
    T K Mutabingwa
    Department of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London, UK
    Acta Trop 95:305-15. 2005
  2. pmc The impact of endemic and epidemic malaria on the risk of stillbirth in two areas of Tanzania with different malaria transmission patterns
    Ulrika Uddenfeldt Wort
    Division of International Health IHCAR, Karolinska Institutet, Stockholm, Sweden
    Malar J 5:89. 2006
  3. pmc Amodiaquine and artemether-lumefantrine select distinct alleles of the Plasmodium falciparum mdr1 gene in Tanzanian children treated for uncomplicated malaria
    G S Humphreys
    Department of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, Keppel Street, London WC1E 7HT, United Kingdom
    Antimicrob Agents Chemother 51:991-7. 2007
  4. ncbi request reprint Monitoring of drug-resistant malaria in Africa
    T K Mutabingwa
    Lancet 360:875. 2002
  5. ncbi request reprint A trial of proguanil-dapsone in comparison with sulfadoxine-pyrimethamine for the clearance of Plasmodium falciparum infections in Tanzania
    T K Mutabingwa
    Amani Medical Research Centre, Box 4, Amani, Tanga, Tanzania
    Trans R Soc Trop Med Hyg 95:433-8. 2001
  6. ncbi request reprint Intensity of malaria transmission, antimalarial-drug use and resistance in Uganda: what is the relationship between these three factors?
    A O Talisuna
    Ministry of Health, P O Box 7272, Kampala, Uganda
    Trans R Soc Trop Med Hyg 96:310-7. 2002
  7. ncbi request reprint WHO, the Global Fund, and medical malpractice in malaria treatment
    Bill Watkins
    Lancet 363:1161-2. 2004
  8. ncbi request reprint Population-based validation of dihydrofolate reductase gene mutations for the prediction of sulfadoxine-pyrimethamine resistance in Uganda
    A O Talisuna
    Ministry of Health, Kampala, Uganda
    Trans R Soc Trop Med Hyg 97:338-42. 2003
  9. pmc Ancillary-care responsibilities in observational research: two cases, two issues
    N Dickert
    Johns Hopkins University School of Medicine and Bloomberg School of Public Health, 600 North Wolfe Street, Baltimore, MD 21287, USA
    Lancet 369:874-7. 2007

Collaborators

Detail Information

Publications9

  1. ncbi request reprint Artemisinin-based combination therapies (ACTs): best hope for malaria treatment but inaccessible to the needy!
    T K Mutabingwa
    Department of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London, UK
    Acta Trop 95:305-15. 2005
    ..Active involvement of scientists from malaria endemic countries in recent International Scientific Forums like the Malaria in Pregnancy Working Group and the Consortium on ACT Implementation is the best way forward to emulate...
  2. pmc The impact of endemic and epidemic malaria on the risk of stillbirth in two areas of Tanzania with different malaria transmission patterns
    Ulrika Uddenfeldt Wort
    Division of International Health IHCAR, Karolinska Institutet, Stockholm, Sweden
    Malar J 5:89. 2006
    ..The aim of the present analysis was to determine comparative changes in stillbirth prevalence between two areas of Tanzania with different malaria transmission patterns in order to estimate the malaria attributable component...
  3. pmc Amodiaquine and artemether-lumefantrine select distinct alleles of the Plasmodium falciparum mdr1 gene in Tanzanian children treated for uncomplicated malaria
    G S Humphreys
    Department of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, Keppel Street, London WC1E 7HT, United Kingdom
    Antimicrob Agents Chemother 51:991-7. 2007
    ..25; 95% confidence interval, 4.17 to 1441; P, <0.001). We conclude that AL and AQ exert opposite within-host selective effects on the Pfmdr1 gene of P. falciparum...
  4. ncbi request reprint Monitoring of drug-resistant malaria in Africa
    T K Mutabingwa
    Lancet 360:875. 2002
  5. ncbi request reprint A trial of proguanil-dapsone in comparison with sulfadoxine-pyrimethamine for the clearance of Plasmodium falciparum infections in Tanzania
    T K Mutabingwa
    Amani Medical Research Centre, Box 4, Amani, Tanga, Tanzania
    Trans R Soc Trop Med Hyg 95:433-8. 2001
    ..With the rising incidence of SP-resistant P. falciparum infection, PG-DS could provide an effective, affordable and already available therapeutic alternative for malaria in East Africa at least until chlorproguanil-dapsone is registered...
  6. ncbi request reprint Intensity of malaria transmission, antimalarial-drug use and resistance in Uganda: what is the relationship between these three factors?
    A O Talisuna
    Ministry of Health, P O Box 7272, Kampala, Uganda
    Trans R Soc Trop Med Hyg 96:310-7. 2002
    ..In low transmission areas, drug pressure seems to be the critical factor. A decrease in transmission coupled with rational use of drugs may delay the spread of resistance...
  7. ncbi request reprint WHO, the Global Fund, and medical malpractice in malaria treatment
    Bill Watkins
    Lancet 363:1161-2. 2004
  8. ncbi request reprint Population-based validation of dihydrofolate reductase gene mutations for the prediction of sulfadoxine-pyrimethamine resistance in Uganda
    A O Talisuna
    Ministry of Health, Kampala, Uganda
    Trans R Soc Trop Med Hyg 97:338-42. 2003
    ..Atthe population level, the dhfr codon 59 M/W ratio is a simple and stable index for the estimation of SP treatment failure...
  9. pmc Ancillary-care responsibilities in observational research: two cases, two issues
    N Dickert
    Johns Hopkins University School of Medicine and Bloomberg School of Public Health, 600 North Wolfe Street, Baltimore, MD 21287, USA
    Lancet 369:874-7. 2007